Glycolipid-mediated basophil activation in alpha-gal allergy - 05/08/20
Supported by National Institutes of Health (NIH) (grants UM1AI30936 to the University of North Carolina [UNC] Food Allergy Initiative and R01AI135049). O. I. Iweala was supported by NIH grant T32AI007062 and a 2019 Thurston Arthritis Research Center Pilot Award. P. J. Brennan was supported by the NIH (grant K08AI102945) and generous support from the Goodfellow and Karol families. The UNC Flow Cytometry Core Facility is supported in part by the NIH (grant P30CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center). Research reported in this publication was supported in part by the North Carolina Biotech Center (institutional support grant 2017-IDG-1025) and by the NIH (grant 1UM2AI30836-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the letter. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 146 - N° 2
P. 450-452 - Agosto 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?